Clinical Trials Logo

Clinical Trial Summary

Evaluate PLR and NLR and their assiotation to vascular complications and glycemic control in type 2 DM


Clinical Trial Description

Vascular complications of DM result from various disorders including metabolic, cellular, and blood disturbances. Excessive production of pro-inflammatory adipokines from adipose tissue, resulting in low-grade chronic inflammation, causing insulin resistance (IR) and type 2 DM [3]. Hematological changes affecting the red blood cells (RBCs), white blood cells (WBCs), platelet function, and the coagulation factors are detected to be associated with DM . It is important to add that, high WBC count, one of the chief components of inflammatory process, sharing to atheroscle-rosis development and cardiovascular diseases (CVD) . Lately, the neutrophil-to-lymphocyte (N/L) and the platelet-to-lymphocyte (P/L) ratios, were offered as markers of inflammation in cardiac diseases, neoplasms and diabetes-related complications . Moreover, high leucocyte counts have been used as diagnostic and prognostic markers in vascular complication of diabetes ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06073756
Study type Observational
Source Assiut University
Contact Ammar Ashraf Fathy
Phone 01028177808
Email ammarashraf154@gmail.com
Status Not yet recruiting
Phase
Start date December 2023
Completion date December 2027